GlycoMimetics, Inc. (GLYC)

GlycoMimetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	41.79	47.87	90.31	137.09	158.25
Cash & Cash Equivalents	41.79	47.87	90.31	137.09	158.25
Cash Growth	-12.70%	-46.99%	-34.12%	-13.37%	-24.63%
Other Current Assets	2	2.84	0.48	1.19	4.27
Total Current Assets	43.79	50.71	90.79	138.27	162.53
Property, Plant & Equipment	0.77	0.75	1.95	2.95	3.83
Other Long-Term Assets	0.76	0.34	1.61	1.61	1.61
Total Long-Term Assets	1.53	1.1	3.56	4.56	5.44
Total Assets	45.32	51.81	94.35	142.83	167.97
Accounts Payable	0.87	0.97	2.11	2.09	1.44
Current Debt	0.74	0.92	1	0.9	0.8
Other Current Liabilities	5.23	6.99	8.72	9.44	8.71
Total Current Liabilities	6.84	8.88	11.82	12.43	10.95
Long-Term Debt	0.07	0	0.92	1.92	2.82
Other Long-Term Liabilities	0	0	0	0.26	0
Total Long-Term Liabilities	0.07	0	0.92	2.18	2.82
Total Liabilities	6.9	8.88	12.74	14.61	13.77
Total Debt	0.81	0.92	1.92	2.82	3.62
Debt Growth	-11.99%	-52.16%	-31.88%	-22.20%	-
Retained Earnings	-456.49	-419.59	-372.9	-309.47	-258.44
Shareholders' Equity	38.41	42.93	81.6	128.22	154.2
Net Cash / Debt	40.98	46.95	88.39	134.27	154.63
Net Cash / Debt Growth	-12.71%	-46.88%	-34.17%	-13.17%	-26.36%
Net Cash Per Share	0.65	0.89	1.72	2.94	3.57
Working Capital	36.96	41.83	78.96	125.84	151.58
Book Value Per Share	0.61	0.82	1.59	2.80	3.56

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).